NSPR

InspireMD to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[PR Newswire] – BOSTON, May 9, 2014 /PRNewswire/ — InspireMD, Inc. (NYSE MKT: NSPR) (InspireMD or the Company), today announced that its CEO, Alan Milinazzo, will be presenting at the Bank of … moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring next, click here to view […]

InspireMD Announces Positive Results from iMOS Prime Registry for the MGuard Prime EPS

[PR Newswire] – BOSTON, May 7, 2014 /PRNewswire/ — InspireMD, Inc. (InspireMD or the Company) (NYSE MKT: NSPR), a leader in embolic protection stents (EPS), today announced new results from the iMOS (International MGuard Observational Study) Prime Regis moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring next, […]

InspireMD Reports Financial Results for the First Quarter Ended March 31, 2014

[PR Newswire] – BOSTON, May 7, 2014 /PRNewswire/ — InspireMD, Inc. (NYSE MKT: NSPR) (InspireMD or the Company), a leader in embolic protection systems (EPS), today announced financial … moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring next, click here to view […]

SHAREHOLDER ALERT: Investigation on Behalf of InspireMD, Inc. Investors Announced by Law Offices of Howard G. Smith

[Business Wire] – Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of InspireMD, Inc. . The inv moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring next, click here to view […]

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of InspireMD – NSPR

[PR Newswire] – NEW YORK, April 30, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of InspireMD, Inc. (InspireMD or the Company) (NYSE MKT: NSPR) (CUSIP:45779A101). Investors are advised to contact Robert S. Willoughby moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring […]

InspireMD to Present at the Cowen & Company 34th Annual Health Care Conference

[PR Newswire] – BOSTON, Feb. 27, 2014 /PRNewswire/ — InspireMD, Inc. (NYSE MKT: NSPR) (InspireMD or the Company), today announced that its CEO, Alan Milinazzo, will be presenting at the Cowen … moreView todays social media effects on NSPRView the latest stocks trending across Twitter. Click to view dashboardSee who InspireMD is hiring next, click here to view […]